Analytical and advisory services
Ten services covering molecular interpretation, case review and strategy. Each states plainly what it delivers and what it does not, because that boundary matters more here than a list of features.
Precision Oncology Consultation
A structured discussion of the molecular and clinical picture in a cancer case, and of the questions it raises.
Molecular Report Review
A detailed reading of a next-generation sequencing or molecular profiling report, including what the assay could and could not detect.
Cancer Second Opinion
An independent re-reading of the clinical, pathological and molecular record in a complex case.
Precision Oncology Analysis & Strategy
The flagship service: a structured review of the clinical, pathological, molecular and evidentiary dimensions of a complex cancer case.
Molecular Tumour Board Review
Multidisciplinary review of a case with molecular findings at the centre of the discussion.
Clinical Trial Matching
Identification of trials whose scientific rationale and eligibility criteria plausibly fit a specific case.
Cancer Genetics & Hereditary Risk Review
Review of germline findings and family history, and of what they may mean for the patient and their relatives.
ctDNA / Liquid Biopsy Review
Interpretation of circulating tumour DNA results, including their limits.
Longitudinal Molecular Monitoring
Interpretation of molecular change over time rather than at a single point.
Complex Case Review
Extended review of cases where the clinical, pathological and molecular picture do not straightforwardly agree.